Cite
HARVARD Citation
Sena, L. et al. (2021). Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy. European journal of cancer. pp. 302-309. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sena, L. et al. (2021). Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy. European journal of cancer. pp. 302-309. [Online].